Design and selection of peptides to block the SARS-CoV-2 receptor binding domain by molecular docking

Design and selection of peptides to block the SARS-CoV-2 receptor binding domain by molecular docking

The novel Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is currently one of the most contagious viruses in existence and the cause of the worst pandemic in this century, COVID-19. SARS-CoV-2 infection begins with the recognition of the cellular receptor angiotensin converting enzyme-2...

Full description

Bibliographic Details
Main Authors: Kendra Ramirez-Acosta, Ivan A. Rosales-Fuerte, J. Eduardo Perez-Sanchez, Alfredo Nuñez-Rivera, Josue Juarez, Ruben D. Cadena-Nava
Format: Article
Language:English
Published: Beilstein-Institut 2022-07-01
Series:Beilstein Journal of Nanotechnology
Subjects:
angiotensin converting enzyme-2 (ace2)
antiviral peptides
hydrogen bonds
molecular docking
sars-cov-2 rbd
Online Access:https://doi.org/10.3762/bjnano.13.62

Internet

https://doi.org/10.3762/bjnano.13.62

Similar Items